Illumina Ventures Announces New Partner, Mara Aspinall, Has Joined Its Investment Team
Illumina Ventures today announced that Mara Aspinall, MBA, has joined the Company’s investment team as a Partner.
News
Latest News
Broken String Biosciences Closes $15M Series A Funding Round
Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners...
Lightcast Discovery secures $49 million in Series B financing to commercialize its single-cell platform for functional analysis
Lightcast Discovery Ltd. (“Lightcast” or the “Company”), a life science tools company developing a novel single-cell functional analysis platform, today announced the completion of a £38M (c. $49 million) Series B funding round, led by M Ventures.
Company Spotlight – DELFI Diagnostics
DELFI Diagnostics is developing a new generation of liquid biopsies that could advance these applications. Built on a new method called fragmentomics and amplified by machine learning, DELFI’s approach is already showing promise, providing early detection for lung, liver and other cancers, and could provide essential insights to inform precision medicine.